The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Farhad Ravandi
October 17, 2022
During the Society of Hematologic Oncology (SOHO) 2022 Annual Meeting, Know AML spoke with Farhad Ravandi, MD Anderson Cancer Center, Houston, US. We asked, Will it be possible to treat acute myeloid leukemia (AML) with oral tablets?
Ravandi explains how using intravenous drugs has shown to have reduced efficiency in elderly patients with AML and discusses how new oral treatments, when paired alongside intravenous drugs, have been well tolerated.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.